Overview of the UK Medical Cannabis Market
The value of the UK medical cannabis market is estimated to be more than £2 billion by 2024 if even half of the 1.4 million individuals currently sourcing cannabis illegally for medical reasons were to be granted a prescription. While the UK enjoys a reputation as a globally dominant medical cannabis producer, nearly all products prescribed in the UK are imports. As of 2019, 44.9% of all domestic production was limited to one cultivator and producer, which resulted in two drugs that are not even available for prescription within the private market but are instead prescribed by a hospital specialist under limited conditions for only a very small number of qualifying people. This webinar will discuss the state of the industry today, including recommendations to reform the industry to encourage wider patient access.
Notes:
• Showcase on what’s happening in UK w/ European dimension.
• Overview of the UK.
About Global Go
Global Go provides sophisticated consulting services to the global cannabis and hemp industry. In tandem with strategic allies around the world, Global Go serves clients throughout the world from offices in Austin, Bogota, Chicago, Cyprus, Denver, Johannesburg, London, Los Angeles, Mexico City, New York, Palm Springs, Phoenix, Quito, São Paulo, Silicon Valley, Toronto, and Zurich. Powered by a team of cannabis industry pioneers and world-class consultants, Global Go helps leading cannabis funds and companies assess and enter new markets; acquire assets; raise capital; launch new product lines; improve SOPs; comply with regulations; implement technology and security systems; find talent; diagnose and execute solutions to growth obstacles; and apply for cannabis licenses (with a 99% success rate on over 175 cannabis license applications across the United States). Learn more at https://globalgo.consulting.